核仁素在结肠癌组织中的表达及临床意义
Expression and Clinical Significance of Nucleolus in Colon Cancer Tissue
摘要: 目的:核仁素(Nucleolin, NCL)已被证明在肿瘤中发挥重要作用,但结肠癌中NCL表达情况尚不明确。本研究旨在探究NCL在结肠癌中的表达情况与结肠癌临床病理特征以及预后的关系。方法:回顾性分析了青岛大学附属医院胃肠外科的184例结肠癌患者病历资料。采用免疫组织化学法检测研究对象组织标本的NCL表达情况。使用SPSS软件进行统计学分析。采用卡方检验比较NCL表达与临床特征间的关系。绘制生存曲线比较组间生存差异。使用Cox比例风险模型进行单因素和多因素分析。结果:细胞核NCL的高低表达与患者的脉管侵犯、T分期、N分期以及TNM分期有关;细胞膜NCL的高低表达与肿瘤大小、大体类型、脉管侵犯、T分期、N分期、M分期和TNM分期有关。与NCL高表达患者相比,NCL低表达患者预后总生存期更好。单因素Cox分析结果显示,肿瘤部位、肿瘤大小、脉管侵犯、TNM分期、细胞核NCL表达情况、细胞膜NCL表达情况为结肠癌患者总生存期的影响因素。多因素结果发现:肿瘤部位、TNM分期、NCL表达情况是影响结肠癌患者生存的独立预后因素。结论:结肠癌组织中NCL的高表达会导致较差的预后。膜NCL高表达与肿瘤的侵袭性相关。NCL与结肠癌患者的OS密切相关,是影响结肠癌患者预后的独立危险因素。
Abstract: Objective: Nucleolin (NCL) has been shown to play an important role in tumors, but the expression of NCL in colon cancer is still unclear. The aim of this study is to explore the relationship between the expression of NCL in colon cancer and the clinical pathological characteristics and prognosis of colon cancer. Method: A retrospective analysis was conducted on the medical records of 184 patients with colon cancer from the Department of Gastrointestinal, Affiliated Hospital of Qingdao University. Immunohistochemical method was used to detect the expression of NCL in the tissue samples of the study subjects. Perform statistical analysis using SPSS software. Use chi square test to compare the relationship between NCL expression and clinical features. Draw survival curves to compare survival differences between groups. Use Cox proportional risk model for single factor and multi factor analysis. Result: The high and low expression of nuclear NCL is related to the patient’s vascular invasion, T stage, N stage, and TNM stage; the high and low expression of cell membrane NCL is related to tumor size, gross type, vascular invasion, T stage, N stage, M stage, and TNM stage. Compared with patients with high expression of NCL, patients with low expression of NCL have a better overall survival prognosis. The results of univariate Cox analysis showed that tumor location, tumor size, vascular invasion, TNM staging, nuclear NCL expression, and cell membrane NCL expression were the influencing factors on the overall survival of colon cancer patients. Multivariate results showed that tumor location, TNM staging, and NCL expression were independent prognostic factors affecting the survival of colon cancer patients. Conclusion: High expression of NCL in colon cancer tissue can lead to poor prognosis. High expression of membrane NCL is associated with tumor invasiveness. NCL is closely related to the OS of colon cancer patients and is an independent risk factor affecting the prognosis of colon cancer patients.
文章引用:曲竑宇, 李泽群, 刘学超, 李毅, 牛兆建. 核仁素在结肠癌组织中的表达及临床意义[J]. 临床医学进展, 2024, 14(3): 2182-2195. https://doi.org/10.12677/acm.2024.143961

参考文献

[1] Sung, H., Ferlay, J., Siegel, R.L, et al. (2021) Global Cancer Statistics 2020: GLOBOCAN Estimates of Incidence and Mortality Worldwide for 36 Cancers in 185 Countries. CA: A Cancer Journal for Clinicians, 71, 209-249. [Google Scholar] [CrossRef] [PubMed]
[2] Bray, F., Ferlay, J., Soerjomataram, I., et al. (2018) Global Cancer Statistics 2018: GLOBOCAN Estimates of Incidence and Mortality Worldwide for 36 Cancers in 185 Countries. CA: A Cancer Journal for Clinicians, 68, 394-424. [Google Scholar] [CrossRef] [PubMed]
[3] Bailey, C.E., Hu, C.Y., You, Y.N., et al. (2015) Increasing Disparities in the Age-Related Incidences of Colon and Rectal Cancers in the United States, 1975-2010. JAMA Surgery, 150, 17-22. [Google Scholar] [CrossRef] [PubMed]
[4] Kasi, P.M., Shahjehan, F., Cochuyt, J.J., et al. (2019) Rising Proportion of Young Individuals with Rectal and Colon Cancer. Clinical Colorectal Cancer, 18, E87-E95. [Google Scholar] [CrossRef] [PubMed]
[5] Henrikson, N.B., Webber, E.M., Goddard, K.A., et al. (2015) Family History and the Natural History of Colorectal Cancer: Systematic Review. Genetics in Medicine: Official Journal of the American College of Medical Genetics, 17, 702-712. [Google Scholar] [CrossRef] [PubMed]
[6] Schoen, R.E., Razzak, A., Yu, K.J., et al. (2015) Incidence and Mortality of Colorectal Cancer in Individuals with a Family History of Colorectal Cancer. Gastroenterology, 149, 1438-1445.E1. [Google Scholar] [CrossRef] [PubMed]
[7] Lowery, J.T., Ahnen, D.J., Schroy, P.C., et al. (2016) Understanding the Contribution of Family History to Colorectal Cancer Risk and Its Clinical Implications: A State-of-the-Science Review. Cancer, 122, 2633-2645. [Google Scholar] [CrossRef] [PubMed]
[8] Syngal, S., Brand, R.E., Church, J.M., et al. (2015) ACG Clinical Guideline: Genetic Testing and Management of Hereditary Gastrointestinal Cancer Syndromes. The American Journal of Gastroenterology, 110, 223-262. [Google Scholar] [CrossRef] [PubMed]
[9] Brenner, H., Chang-Claude, J., Seiler, C.M., et al. (2011) Protection from Colorectal Cancer after Colonoscopy: A Population-Based, Case-Control Study. Annals of Internal Medicine, 154, 22-30. [Google Scholar] [CrossRef] [PubMed]
[10] Morris, E.J., Rutter, M.D., Finan, P.J., et al. (2015) Post-Colonoscopy Colorectal Cancer (PCCRC) Rates Vary Considerably Depending on the Method Used to Calculate Them: A Retrospective Observational Population-Based Study of PCCRC in the English National Health Service. Gut, 64, 1248-1256. [Google Scholar] [CrossRef] [PubMed]
[11] Kaminski, M.F., Regula, J., Kraszewska, E., et al. (2010) Quality Indicators for Colonoscopy and the Risk of Interval Cancer. The New England Journal of Medicine, 362, 1795-1803. [Google Scholar] [CrossRef
[12] Thompson, M.R., Perera, R., Senapati, A., et al. (2007) Predictive Value of Common Symptom Combinations in Diagnosing Colorectal Cancer. The British Journal of Surgery, 94, 1260-1265. [Google Scholar] [CrossRef] [PubMed]
[13] Tajrishi, M.M., Tuteja, R. and Tuteja, N. (2011) Nucleolin: The Most Abundant Multifunctional Phosphoprotein of Nucleolus. Communicative & Integrative Biology, 4, 267-275. [Google Scholar] [CrossRef] [PubMed]
[14] Orrick, L.R., Olson, M.O. and Busch, H. (1973) Comparison of Nucleolar Proteins of Normal Rat Liver and Novikoff Hepatoma Ascites Cells by Two-Dimensional Polyacrylamide Gel Electrophoresis. Proceedings of the National Academy of Sciences of the United States of America, 70, 1316-1320. [Google Scholar] [CrossRef] [PubMed]
[15] Jia, W., Yao, Z., Zhao, J., et al. (2017) New Perspectives of Physiological and Pathological Functions of Nucleolin (NCL). Life Sciences, 186, 1-10. [Google Scholar] [CrossRef] [PubMed]
[16] Chen, Z. and Xu, X. (2016) Roles of Nucleolin. Focus on Cancer and Anti-Cancer Therapy. Saudi Medical Journal, 37, 1312-1318. [Google Scholar] [CrossRef] [PubMed]
[17] Tonello, F., Massimino, M.L. and Peggion, C. (2022) Nucleolin: A Cell Portal for Viruses, Bacteria, and Toxins. Cellular and Molecular Life Sciences: CMLS, 79, Article No. 271. [Google Scholar] [CrossRef] [PubMed]
[18] Raska, I., Shaw, P.J. and Cmarko, D. (2006) New Insights into Nucleolar Architecture and Activity. International Review of Cytology, 255, 177-235. [Google Scholar] [CrossRef
[19] Wang, X., Cheng, H., Hu, D., et al. (2023) Nucleolin Promotes Tumor Growth in Colorectal Cancer by Enhancing HnRNPA1-Mediated PKM2 Alternative Splicing. Genes & Diseases, 10, 2237-2240. [Google Scholar] [CrossRef] [PubMed]
[20] Satake, Y., Kuwano, Y., Nishikawa, T., et al. (2018) Nucleolin Facilitates Nuclear Retention of an Ultraconserved Region Containing TRA2β4 and Accelerates Colon Cancer Cell Growth. Oncotarget, 9, 26817-26833. [Google Scholar] [CrossRef] [PubMed]
[21] Wang, X., Yu, H., Sun, W., et al. (2018) The Long Non-Coding RNA CYTOR Drives Colorectal Cancer Progression by Interacting with NCL and Sam68. Molecular Cancer, 17, Article No. 110. [Google Scholar] [CrossRef] [PubMed]
[22] Kirman, D.C., Renganathan, B., Chui, W.K., et al. (2022) Cell Surface Nucleolin Is a Novel ADAMTS5 Receptor Mediating Endothelial Cell Apoptosis. Cell Death & Disease, 13, Article No. 172. [Google Scholar] [CrossRef] [PubMed]
[23] Berger, C.M., Gaume, X. and Bouvet, P. (2015) The Roles of Nucleolin Subcellular Localization in Cancer. Biochimie, 113, 78-85. [Google Scholar] [CrossRef] [PubMed]
[24] Wise, J.F., Berkova, Z., Mathur, R., et al. (2013) Nucleolin Inhibits Fas Ligand Binding and Suppresses Fas-Mediated Apoptosis in Vivo via a Surface Nucleolin-Fas Complex. Blood, 121, 4729-4739. [Google Scholar] [CrossRef] [PubMed]
[25] Farin, K., Schokoroy, S., Haklai, R., et al. (2011) Oncogenic Synergism Between ErbB1, Nucleolin, and Mutant Ras. Cancer Research, 71, 2140-2151. [Google Scholar] [CrossRef
[26] Qi, J., Li, H., Liu, N., et al. (2015) The Implications and Mechanisms of the Extra-Nuclear Nucleolin in the Esophageal Squamous Cell Carcinomas. Medical Oncology (Northwood, London, England), 32, Article No. 45. [Google Scholar] [CrossRef] [PubMed]
[27] Fujiki, H., Watanabe, T. and Suganuma, M. (2014) Cell-Surface Nucleolin Acts as a Central Mediator for Carcinogenic, Anti-Carcinogenic, and Disease-Related Ligands. Journal of Cancer Research and Clinical Oncology, 140, 689-699. [Google Scholar] [CrossRef] [PubMed]
[28] Yangngam, S., Prasopsiri, J., Hatthakarnkul, P., et al. (2022) Cellular Localization of Nucleolin Determines the Prognosis in Cancers: A Meta-Analysis. Journal of Molecular Medicine (Berlin, Germany), 100, 1145-1157. [Google Scholar] [CrossRef] [PubMed]
[29] Wu, D.M., Zhang, P., Liu, R.Y., et al. (2014) Phosphorylation and Changes in the Distribution of Nucleolin Promote Tumor Metastasis via the PI3K/Akt Pathway in Colorectal Carcinoma. FEBS Letters, 588, 1921-1929. [Google Scholar] [CrossRef] [PubMed]
[30] Yang, Y., Yang, C. and Zhang, J. (2015) C23 Protein Meditates Bone Morphogenetic Protein-2-Mediated EMT via Up-Regulation of Erk1/2 and Akt in Gastric Cancer. Medical Oncology (Northwood, London, England), 32, Article No. 76. [Google Scholar] [CrossRef] [PubMed]
[31] Qiu, W., Zhou, F., Zhang, Q., et al. (2013) Overexpression of Nucleolin and Different Expression Sites both Related to the Prognosis of Gastric Cancer. APMIS: Acta Pathologica, Microbiologica, et Immunologica Scandinavica, 121, 919-925. [Google Scholar] [CrossRef] [PubMed]
[32] Azman, M.S., Alard, E.L., Dodel, M., et al. (2023) An ERK1/2-Driven RNA-Binding Switch in Nucleolin Drives Ribosome Biogenesis and Pancreatic Tumorigenesis Downstream of RAS Oncogene. The EMBO Journal, 42, E110902. [Google Scholar] [CrossRef] [PubMed]
[33] Tominaga, K., Srikantan, S., Lee, E.K., et al. (2011) Competitive Regulation of Nucleolin Expression by HuR and MiR-494. Molecular and Cellular Biology, 31, 4219-4231. [Google Scholar] [CrossRef
[34] Soundararajan, S., Chen, W., Spicer, E.K., et al. (2008) The Nucleolin Targeting Aptamer AS1411 Destabilizes Bcl-2 Messenger RNA in Human Breast Cancer Cells. Cancer Research, 68, 2358-2365. [Google Scholar] [CrossRef
[35] Chen, S.C., Hu, T.H., Huang, C.C., et al. (2015) Hepatoma-Derived Growth Factor/Nucleolin Axis as a Novel Oncogenic Pathway in Liver Carcinogenesis. Oncotarget, 6, 16253-16270. [Google Scholar] [CrossRef] [PubMed]
[36] Guo, X., Xiong, L., Yu, L., et al. (2014) Increased Level of Nucleolin Confers to Aggressive Tumor Progression and Poor Prognosis in Patients with Hepatocellular Carcinoma after Hepatectomy. Diagnostic Pathology, 9, Article No. 175. [Google Scholar] [CrossRef] [PubMed]
[37] Schokoroy, S., Juster, D., Kloog, Y., et al. (2013) Disrupting the Oncogenic Synergism between Nucleolin and Ras Results in Cell Growth Inhibition and Cell Death. PLOS ONE, 8, E75269. [Google Scholar] [CrossRef] [PubMed]
[38] Zhang, B., Wang, H., Jiang, B., et al. (2010) Nucleolin/C23 Is a Negative Regulator of Hydrogen Peroxide-Induced Apoptosis in HUVECs. Cell Stress & Chaperones, 15, 249-257. [Google Scholar] [CrossRef] [PubMed]
[39] Fogal, V., Sugahara, K.N., Ruoslahti, E., et al. (2009) Cell Surface Nucleolin Antagonist Causes Endothelial Cell Apoptosis and Normalization of Tumor Vasculature. Angiogenesis, 12, 91-100. [Google Scholar] [CrossRef] [PubMed]